Regencell Bioscience Holdings Ltd. (RGC)
5.27
0.00 (0.00%)
USD |
NASDAQ |
Nov 06, 16:00
5.33
+0.06
(+1.14%)
After-Hours: 20:00
Regencell Bioscience Holdings Max Drawdown (5Y) : 93.87% for Oct. 31, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2026 | 93.87% |
| September 30, 2026 | 93.87% |
| August 31, 2026 | 93.87% |
| July 31, 2026 | 93.87% |
| June 30, 2026 | 93.09% |
| May 31, 2026 | 93.09% |
| April 30, 2026 | 93.09% |
| March 31, 2026 | 93.09% |
| Date | Value |
|---|---|
| February 28, 2026 | 93.09% |
| January 31, 2026 | 93.09% |
| December 31, 2025 | 93.09% |
| November 30, 2025 | 93.09% |
| October 31, 2025 | 93.09% |
| September 30, 2025 | 93.09% |
| August 31, 2025 | 93.09% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| HUTCHMED (China) Ltd. | 82.18% |
| Regent Pacific Group Ltd. | 99.98% |
| SSY Group Ltd. | 41.86% |
| Sino Biopharmaceutical Ltd. | 76.27% |
| Beijing Tong Ren Tang Chinese Medicine Co., Ltd. | 56.77% |